These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 21924209)

  • 21. Putative role of endocannabinoid signaling in the etiology of depression and actions of antidepressants.
    Gorzalka BB; Hill MN
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1575-85. PubMed ID: 21111017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression.
    Blier P; de Montigny C; Chaput Y
    J Clin Psychopharmacol; 1987 Dec; 7(6 Suppl):24S-35S. PubMed ID: 3323264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review of treatment studies of depression in HIV.
    Olatunji BO; Mimiaga MJ; O'Cleirigh C; Safren SA
    Top HIV Med; 2006; 14(3):112-24. PubMed ID: 16946456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current status of antidepressants: clinical pharmacology and therapy.
    Baldessarini RJ
    J Clin Psychiatry; 1989 Apr; 50(4):117-26. PubMed ID: 2647712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Depression and pain comorbidity: a literature review.
    Bair MJ; Robinson RL; Katon W; Kroenke K
    Arch Intern Med; 2003 Nov; 163(20):2433-45. PubMed ID: 14609780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of depression--newer pharmacotherapies.
    Mulrow CD; Williams JW; Trivedi M; Chiquette E; Aguilar C; Cornell JE; Badgett R; Noël PH; Lawrence V; Lee S; Luther M; Ramirez G; Richardson WS; Stamm K
    Psychopharmacol Bull; 1998; 34(4):409-795. PubMed ID: 10513454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neurobiological mechanisms of depression and antidepressant therapy].
    Shishkina GT; Dygalo NN
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2010; 60(2):138-52. PubMed ID: 20469588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence that the pathophysiology of depression and the mechanism of action of antidepressant drugs both involve alterations in circadian rhythms.
    Goodwin FK; Wirz-Justice A; Wehr TA
    Adv Biochem Psychopharmacol; 1982; 32():1-11. PubMed ID: 6124089
    [No Abstract]   [Full Text] [Related]  

  • 29. Depression 2: Exploring management options for adults with moderate to severe symptoms.
    Masterson B; Taylor C; Pilling S
    Nurs Times; 2010 Aug 17-23; 106(32):23-4. PubMed ID: 20879642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mechanism of action of antidepressants and therapeutic perspectives].
    Bourin M; David DJ; Jolliet P; Gardier A
    Therapie; 2002; 57(4):385-96. PubMed ID: 12422559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Melatonin in mood disorders.
    Srinivasan V; Smits M; Spence W; Lowe AD; Kayumov L; Pandi-Perumal SR; Parry B; Cardinali DP
    World J Biol Psychiatry; 2006; 7(3):138-51. PubMed ID: 16861139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Consensus recommendations for improving adherence, self-management, and outcomes in patients with depression.
    Trivedi MH; Lin EH; Katon WJ
    CNS Spectr; 2007 Aug; 12(8 Suppl 13):1-27. PubMed ID: 17986951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The future of psychopharmacology of depression.
    Chang T; Fava M
    J Clin Psychiatry; 2010 Aug; 71(8):971-5. PubMed ID: 20797377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stretch, Shrink, and Shatter the Rhythms: The Intrinsic Circadian Period in Mania and Depression.
    Martynhak BJ; Pereira M; de Souza CP; Andreatini R
    CNS Neurol Disord Drug Targets; 2015; 14(8):963-9. PubMed ID: 26350335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circadian rhythm, depression, antidepressants, single dose.
    Herrmann L
    Pharmacopsychiatry; 1984 May; 17(3):69-70. PubMed ID: 6739536
    [No Abstract]   [Full Text] [Related]  

  • 36. Management of the depressive component of bipolar disorder.
    Kalin NH
    Depress Anxiety; 1996-1997; 4(4):190-8. PubMed ID: 9166651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Advances in the molecular treatment of depression].
    Páez X; Hernández L; Baptista T
    Rev Neurol; 2003 Sep 1-15; 37(5):459-70. PubMed ID: 14533097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Biological treatment of depression].
    Colonna L
    Rev Prat; 1999 Apr; 49(7):733-8. PubMed ID: 10337218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comorbid depression and anxiety spectrum disorders.
    Gorman JM
    Depress Anxiety; 1996-1997; 4(4):160-8. PubMed ID: 9166648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. From monoamines to genomic targets: a paradigm shift for drug discovery in depression.
    Wong ML; Licinio J
    Nat Rev Drug Discov; 2004 Feb; 3(2):136-51. PubMed ID: 15040578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.